S. Tejpar

Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial).

M. Buyse, E. Van Cutsem, S. Tejpar, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

E. Van Cutsem, J. Tabernero, F. Ciardiello, 2015, British Journal of Cancer.

Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer

P. Dunne, C. Isella, L. Trusolino, 2024, Nature genetics.

Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.

C. Sotiriou, M. Piccart, P. Laurent-Puig, 2015, Cancer treatment reviews.

The ZIC gene family encodes multi-functional proteins essential for patterning and morphogenesis

Rob Houtmeyers, S. Tejpar, Jacob Souopgui, 2013, Cellular and Molecular Life Sciences.

Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells

M. Caraglia, E. Van Cutsem, F. Ciardiello, 2012, British Journal of Cancer.

KRAS, NRAS, BRAF mutation comparison of endoscopic and surgically removed primary CRC paired samples: is endoscopy biopsy material adequate for molecular evaluation?

S. Tejpar, G. De Hertogh, G. Hertogh, 2015, British Journal of Cancer.

Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology.

P. Lambin, V. Velculescu, P. Jänne, 2019, European journal of cancer.

KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assurance

P. Quirke, S. Tejpar, J. E. Boers, 2012, Virchows Archiv.

Dose-escalation study using up to twice the standard dose of cetuximab in patients with metastatic colorectal cancer (mCRC) with no or slight skin reactions on cetuximab standard dose treatment (EVEREST study): Preliminary data.

E. Van Cutsem, F. Ciardiello, Y. Humblet, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.